Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications
Mauro Cives, Eleonora Pellè, Davide Quaresmini, et al.
Neuroendocrinology (2019) Vol. 109, Iss. 2, pp. 83-99
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Gastrointestinal neuroendocrine tumors in 2020
Monjur Ahmed∥
World Journal of Gastrointestinal Oncology (2020) Vol. 12, Iss. 8, pp. 791-807
Open Access | Times Cited: 189
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Jaume Capdevila, Nicola Fazio, Carlos López, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2304-2312
Open Access | Times Cited: 81
Mesenteric Fibrosis in Neuroendocrine Neoplasms: a Systematic Review of New Thoughts on Causation and Potential Treatments
Ariadni Spyroglou, Odysseas Violetis, Konstantinos Iliakopoulos, et al.
Current Oncology Reports (2025)
Open Access | Times Cited: 1
Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome
Dominique Clement, John Ramage, Raj Srirajaskanthan
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 64
FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies
Katharina Dendl, Rebecca Finck, Frederik L. Giesel, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 2, pp. 721-731
Open Access | Times Cited: 48
Role of Somatostatin Signalling in Neuroendocrine Tumours
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 34
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
Kenta Kawasaki, Natasha Rekhtman, Álvaro Quintanal-Villalonga, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 16-32
Closed Access | Times Cited: 33
Neuroendocrine Neoplasms of the Gynecologic Tract
Mayur Virarkar, Sai Swarupa Vulasala, Ajaykumar C. Morani, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1835-1835
Open Access | Times Cited: 31
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors
Wuhu Zhang, Wenquan Wang, Xuan Han, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001188-e001188
Open Access | Times Cited: 43
Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
Taymeyah Al‐Toubah, Þorvarður R. Hálfdánarson, Jennifer Gile, et al.
ESMO Open (2021) Vol. 7, Iss. 1, pp. 100364-100364
Open Access | Times Cited: 34
Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)
Grigoris Effraimidis, Ulrich Knigge, Maria Rossing, et al.
Seminars in Cancer Biology (2021) Vol. 79, pp. 141-162
Closed Access | Times Cited: 33
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
Barbara Mandriani, Eleonora Pellè, Francesco Mannavola, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004854-e004854
Open Access | Times Cited: 24
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
Barbara Altieri, Carla Di Dato, Chiara Martini, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1332-1332
Open Access | Times Cited: 37
"Present and future of immunotherapy in Neuroendocrine Tumors"
Manuela Albertelli, Andrea Dotto, Federica Nista, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 615-636
Open Access | Times Cited: 31
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
Anja Rinke, Christoph J. Auernhammer, Lisa Bodei, et al.
Gut (2021) Vol. 70, Iss. 9, pp. 1768-1781
Closed Access | Times Cited: 30
Serum Inflammation-based Scores in Endocrine Tumors
Pedro Marques, Friso de Vries, Olaf M. Dekkers, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e3796-e3819
Open Access | Times Cited: 29
Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
Rosa Fonti, Mariarosaria Panico, Sara Pellegrino, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 10, pp. 1509-1514
Open Access | Times Cited: 20
Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha‐smooth muscle actin‐positive fibrosis and COMP‐expressing stromal cells
Sebastián Graf, Corinna U. Keber, Akira Hattesohl, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 2
Open Access | Times Cited: 4
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
Ilaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 832-832
Open Access | Times Cited: 32
Novel immunotherapy strategies for treatment of neuroendocrine neoplasms
Taymeyah Al‐Toubah, Mauro Cives, Jonathan Strosberg
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 54-54
Open Access | Times Cited: 31
The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms
Wu-Hu Zhang, Wenquan Wang, Heli Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 2, pp. 188311-188311
Open Access | Times Cited: 30
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Eleonora Pellè, Jonathan Strosberg
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3655-3655
Open Access | Times Cited: 30
Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review
Anna Koumarianou, Krystallenia Alexandraki, Göran Wallin, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1777-1777
Open Access | Times Cited: 28
CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor
Rami Imam, Qing Chang, Margaret A. Black, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
Jianming Xu
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top